TicoVac 1.2 ug/.25mL

TicoVac 1.2 ug/0.25mL is a vaccine designed to protect against tick-borne encephalitis. This injection is manufactured by Pfizer Laboratories and is administered intramuscularly. Learn more about its uses and effects.

TicoVac is primarily used to prevent tick-borne encephalitis, a viral infection spread through tick bites. This vaccine is intended for individuals who may be at risk of exposure to ticks in endemic areas. It works by stimulating the body's immune response to develop protection against the virus.

Common effects of TicoVac may include mild soreness, redness, or swelling at the injection site. Some individuals might experience temporary fatigue, headache, or muscle aches. These effects are generally mild and short-lived.

TicoVac should be administered by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Follow the storage and handling instructions provided to maintain the vaccine's efficacy.

There are no specific interactions widely reported with TicoVac. However, it is always advisable to discuss any medications or supplements you are taking with your healthcare provider before receiving the vaccine.